2022
DOI: 10.1016/j.xjidi.2021.100091
|View full text |Cite
|
Sign up to set email alerts
|

Training and Retaining Physician–Scientists in Dermatology: A United Kingdom Perspective

Abstract: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(3 citation statements)
references
References 5 publications
0
3
0
Order By: Relevance
“…3 The allocation of relatively small grants can enable research experience and prompt interest in academic dermatology. 4 This study highlights the excellent quality and volume of research output supported by research bursaries from the CDSCHC, and emphasizes the importance of grassroots funding for trainee dermatologists in Ireland.…”
Section: Recruitment Ongoingmentioning
confidence: 70%
See 2 more Smart Citations
“…3 The allocation of relatively small grants can enable research experience and prompt interest in academic dermatology. 4 This study highlights the excellent quality and volume of research output supported by research bursaries from the CDSCHC, and emphasizes the importance of grassroots funding for trainee dermatologists in Ireland.…”
Section: Recruitment Ongoingmentioning
confidence: 70%
“…3 Helpfully, the British Association of Dermatologists (BAD) has produced a list of 'Top Tips' to help target follow-up to those patients who really need it. 4 Essentially, the guide broadly advises retaining only those patients on a recognized skin cancer surveillance pathway or those taking a systemic drug requiring hospital monitoring. For patients on topical therapies but potentially on the cusp of a systemic therapy, patient-initiated follow-up for a finite period is advised by the BAD.…”
mentioning
confidence: 99%
See 1 more Smart Citation